Lorna Warwick

Academic History

Lorna Warwick, BA, completed her studies at the University of Windsor, Windsor, Canada, in 1993. She was a Regional Director for the Canadian Diabetes Association from 2000-2003 and an Executive Director and, subsequently, Senior National Director for The Leukemia & Lymphoma Society of Canada (2003-2014). In December 2018, Ms Warwick was appointed CEO of the Lymphoma Coalition, having previously filled the position of Director of Strategic Communications and Engagement. 

Speaking on patient-centered care and the importance of considering the patient experience when treating hematological malignancies

Ms Warwick has over two decades of experience in evidence-based advocacy, with a focus on hematological malignancies since 2003. She uses this breadth of knowledge and the data from the biennial Lymphoma Coalition Global Patient Survey on Lymphomas and Chronic Lymphocytic Leukemia (CLL) to understand the patient experience, aiming to accurately report on different subgroups of patients. She regularly presents these findings and highlights key challenges faced by patients, which should be addressed by policymakers and healthcare professionals.